Key Financial Data Of Reporting Company

JCR Pharmaceuticals Co.,Ltd. - Filing #7604217

Concept As at
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
51,081,000,000 JPY
51,082,000,000 JPY
30,085,000,000 JPY
30,085,000,000 JPY
24,725,000,000 JPY
24,781,000,000 JPY
22,910,000,000 JPY
23,160,000,000 JPY
20,304,000,000 JPY
20,594,000,000 JPY
Ordinary profit (loss)
20,425,000,000 JPY
20,512,000,000 JPY
8,594,000,000 JPY
8,488,000,000 JPY
3,342,000,000 JPY
3,293,000,000 JPY
5,031,000,000 JPY
5,068,000,000 JPY
3,794,000,000 JPY
3,843,000,000 JPY
Profit (loss)
14,446,000,000 JPY
7,081,000,000 JPY
2,741,000,000 JPY
3,826,000,000 JPY
3,015,000,000 JPY
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
9,061,000,000 JPY
9,061,000,000 JPY
9,061,000,000 JPY
Total number of issued shares
129,686,000 xbrli:shares
129,686,000 xbrli:shares
32,421,000 xbrli:shares
32,421,000 xbrli:shares
32,421,000 xbrli:shares
Net assets
51,089,000,000 JPY
50,939,000,000 JPY
38,557,000,000 JPY
38,546,000,000 JPY
32,579,000,000 JPY
32,278,000,000 JPY
30,874,000,000 JPY
30,524,000,000 JPY
27,049,000,000 JPY
27,528,000,000 JPY
Total assets
97,134,000,000 JPY
97,033,000,000 JPY
73,784,000,000 JPY
73,727,000,000 JPY
47,775,000,000 JPY
47,440,000,000 JPY
42,516,000,000 JPY
42,072,000,000 JPY
37,756,000,000 JPY
38,398,000,000 JPY
Net assets per share
406.57
407.02
306.31
307.64
257.92
257.01
245.54
244.24
217.07
219.46
Dividend paid per share
22.00
25.50
32.00
30.00
26.00
Interim dividend paid per share
10.00
18.00
15.00
13.00
12.00
Basic earnings (loss) per share
116.77
117.26
57.33
55.81
22.23
21.72
31.08
30.17
24.24
24.68
Diluted earnings per share
116.31
116.80
57.05
55.53
22.10
21.59
30.90
30.00
24.09
24.53
Equity-to-asset ratio
0.518 xbrli:pure
0.519 xbrli:pure
0.513 xbrli:pure
0.516 xbrli:pure
0.666 xbrli:pure
0.668 xbrli:pure
0.711 xbrli:pure
0.715 xbrli:pure
0.707 xbrli:pure
0.703 xbrli:pure
Rate of return on equity
0.327 xbrli:pure
0.329 xbrli:pure
0.203 xbrli:pure
0.198 xbrli:pure
0.089 xbrli:pure
0.086 xbrli:pure
0.135 xbrli:pure
0.130 xbrli:pure
0.112 xbrli:pure
0.113 xbrli:pure
Price-earnings ratio
19.3 xbrli:pure
19.2 xbrli:pure
62.5 xbrli:pure
64.2 xbrli:pure
105.9 xbrli:pure
108.4 xbrli:pure
52.4 xbrli:pure
54.0 xbrli:pure
62.6 xbrli:pure
61.5 xbrli:pure
Payout ratio
0.188 xbrli:pure
0.209 xbrli:pure
0.360 xbrli:pure
0.241 xbrli:pure
0.268 xbrli:pure
Net cash provided by (used in) operating activities
9,289,000,000 JPY
10,341,000,000 JPY
4,927,000,000 JPY
3,905,000,000 JPY
3,133,000,000 JPY
Net cash provided by (used in) investing activities
-3,250,000,000 JPY
-3,290,000,000 JPY
-4,161,000,000 JPY
240,000,000 JPY
-1,587,000,000 JPY
Net cash provided by (used in) financing activities
-2,179,000,000 JPY
8,304,000,000 JPY
2,048,000,000 JPY
-917,000,000 JPY
-2,175,000,000 JPY
Cash and cash equivalents
30,733,000,000 JPY
26,260,000,000 JPY
10,928,000,000 JPY
8,091,000,000 JPY
4,850,000,000 JPY
Number of employees
816 xbrli:pure
816 xbrli:pure
797 xbrli:pure
797 xbrli:pure
732 xbrli:pure
719 xbrli:pure
667 xbrli:pure
654 xbrli:pure
632 xbrli:pure
613 xbrli:pure
540 xbrli:pure
568 xbrli:pure
Total shareholder return
3.747 xbrli:pure
5.872 xbrli:pure
3.869 xbrli:pure
2.689 xbrli:pure
2.501 xbrli:pure
Total return on share price index
1.443 xbrli:pure
1.415 xbrli:pure
0.996 xbrli:pure
1.100 xbrli:pure
1.159 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.